Associations between ventilator bundle components and outcomes

JAMA Internal Medicine

Volumn 176, Issue 9, 2016, Pages 1277-1283

  Klompas, Michael ^a,b   Li, Lingling ^a   Kleinman, Ken ^a   Szumita, Paul M ^b   Massaro, Anthony F ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; SEDATIVE AGENT; CHLORHEXIDINE GLUCONATE; HYPNOTIC SEDATIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; EXTUBATION; FEMALE; HEAD OF BED ELEVATION; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MOUTH HYGIENE; PATIENT POSITIONING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPONTANEOUS BREATHING TRIAL; STRESS ULCER; THROMBOSIS PREVENTION; TIME TO TREATMENT; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; ANALOGS AND DERIVATIVES; ANTIBIOTIC PROPHYLAXIS; CARE BUNDLE; EPIDEMIOLOGY; INFECTION CONTROL; INTENSIVE CARE UNIT; MASSACHUSETTS; MIDDLE AGED; MORTALITY; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES; RESPIRATORY CARE; STATISTICS AND NUMERICAL DATA; THROMBOEMBOLISM; ULCER;

AIRWAY EXTUBATION; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; CHLORHEXIDINE; COHORT STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MASSACHUSETTS; MIDDLE AGED; ORAL HYGIENE; PATIENT CARE BUNDLES; PATIENT POSITIONING; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY THERAPY; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; ULCER;

EID: 84998827907     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.2427     Document Type: Article

References (38)

1. Klompas M. Ventilator-associated pneumonia: is zero possible? Clin Infect Dis. 2010;51(10):1123-1126.
2. Youngquist P, Carroll M, Farber M, et al. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf. 2007;33(4): 219-225.
3. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005;31(5):243-248.
4. Talbot TR, Carr D, Parmley CL, et al. Sustained reduction of ventilator-associated pneumonia rates using real-time course correction with a ventilator bundle compliance dashboard. Infect Control Hosp Epidemiol. 2015;36(11):1261-1267.
5. Berenholtz SM, Pham JC, Thompson DA, et al. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol. 2011;32(4):305-314.
6. Bouadma L, Deslandes E, Lolom I, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis. 2010;51 (10):1115-1122.
7. Marra AR, Cal RG, Silva CV, et al. Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control. 2009; 37(8):619-625.
8. Burger CD, Resar RK. "Ventilator bundle" approach to prevention of ventilator-associated pneumonia. Mayo Clin Proc. 2006;81(6):849-850.
9. Bird D, Zambuto A, O'Donnell C, et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg. 2010;145(5):465-470.
10. Stevens JP, Kachniarz B, Wright SB, et al. When policy gets it right: variability in US hospitals' diagnosis of ventilator-associated pneumonia. Crit Care Med. 2014;42(3):497-503.
11. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999;354(9193):1851-1858.
12. van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel FH, et al. Feasibility and effects of the semirecumbent positiontoprevent ventilator-associated pneumonia: a randomized study. Crit Care Med. 2006;34(2):396-402.
13. Keeley L. Reducing the risk of ventilator-acquired pneumonia through head of bed elevation. Nurs Crit Care. 2007;12(6):287-294.
14. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301 (20):2120-2128.
15. Miano TA, Reichert MG, Houle TT, MacGregor DA, Kincaid EH, Bowton DL. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. Chest. 2009;136 (2):440-447.
16. Sasabuchi Y, Matsui H, Lefor AK, Fushimi K, Yasunaga H. Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis. Crit Care Med. 2016;44(7):e464-e469.
17. Price R, MacLennan G, Glen J;SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ. 2014;348:g2197.
18. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med. 2014;174(5):751-761.
19. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477.
20. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.
21. Mehta S, Burry L, Cook D, et al; SLEAP Investigators; Canadian Critical Care Trials Group. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA. 2012;308(19):1985-1992.
22. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
24. Centers for Disease Control and Prevention. Surveillance for ventilator-associated events. http://www.cdc.gov/nhsn/acute-care-hospital/vae/index.html. Published 2014. Accessed March 25, 2014.
25. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
26. van Mourik MS, Moons KG, Murphy MV, Bonten MJ, Klompas M. Severity of disease estimation and risk-adjustment for comparison of outcomes in mechanically ventilated patients using electronic routine care data. Infect Control Hosp Epidemiol. 2015;36(7):807-815.
27. Esteban A, Frutos F, Tobin MJ, et al; Spanish Lung Failure Collaborative Group. A comparison of four methods ofweaning patients from mechanical ventilation. N Engl J Med. 1995;332(6):345-350.
28. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864-1869.
29. Klompas M, Anderson D, Trick W, et al; CDC Prevention Epicenters WakeUp and Breathe Collaborative. The preventability of ventilator-associated events. Am J Respir Crit Care Med. 2015;191(3):292-301.
30. Krein SL, Fowler KE, Ratz D, Meddings J, Saint S. Preventing device-associated infections in US hospitals: national surveys from 2005 to 2013. BMJ Qual Saf. 2015;24(6):385-392.
31. Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2088-2098.
32. Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest. 2011; 140(6):1436-1446.
33. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Møller M. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med. 2014;40(1):11-22.
34. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med. 2010;38(11):2222-2228.
35. Determann RM, Royakkers A, Wolthuis EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care. 2010;14(1):R1.
36. Mekontso Dessap A, Roche-Campo F, Kouatchet A, et al. Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med. 2012;186(12):1256-1263.
37. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373 (9678):1874-1882.
38. Klompas M. Potential strategies to prevent ventilator-associated events. Am J Respir Crit Care Med. 2015;192(12):1420-1430.